SPOTLIGHT: FDA OKs Newron trials


Italy's Newron has won FDA approval to conduct clinical trials of ralfinamide. The decision was announced along with the news that Newron and Purdue had settled their patent dispute regarding ralfinamide and other compounds. Report

Suggested Articles

The clamor for more transparency from the leading pandemic vaccine contenders has been getting louder.

The role gives one of the driving forces behind Bristol Myers Squibb’s $74 billion takeover of Celgene the chance to help build biotechs.

The appointment gives Sino-American biotech Brii the experience of a man who helped Gilead launch eight drugs in China in quick succession.